Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ester
Ester Alonso Frijola, Celra ES
| Patent application number | Description | Published |
|---|---|---|
| 20100170119 | REMOVABLE DEVICE FOR ATTACHING TWO MECHANICAL PARTS - A removable device for attaching two mechanical parts includes a pin removably locking a first part with respect to a second part, a retainer member on the pin and a resiliently loaded tension member which collaborate to prevent the pin from coming out of its locked position; the removable device further includes at least two inclined surfaces, the general shape of which is that of a projection oriented in the axial direction of the pin, such that when the pin rotates, the retainer member runs along the inclined surfaces and the pin moves between the locked position and unlocked position against a force exerted on the pin along a longitudinal axial direction of the pin exerted by the tension member. | 07-08-2010 |
Ester Carballo-Jane, Atlantic Highlands, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110046056 | APOA-1 PEPTIDE MIMETICS - The invention relates to peptide mimetics for treating disorders associated with hypercholesterolemia and cardio-vascular disease. In particular, the invention relates to peptides that mimic the activity of apolipoprotein A-I (Apo AI). | 02-24-2011 |
Ester Fellous, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090143347 | Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depressive disorders and long-term neurological diseases - The invention relates to the therapeutic use of pregnenolone derivatives for treating depressive disorders and long-term neurological diseases. | 06-04-2009 |
Ester Fernandez Gimeno, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20120045389 | METHODS AND REAGENTS FOR EFFICIENT AND TARGETED GENE TRANSFER TO MONOCYTES AND MACROPHAGES - The present invention provides a biosafe and useful vector to transfer genetic material to CD14+ mononuclear cells (monocytes and monocyte-derived macrophages) in an efficient and specific manner. The embodiment of the invention makes use of the chimeric human adenovirus vectors 5 carrying the short fiber of enterotropic Ad40 to transfer genetic material to the target CD14+ mononuclear cells. | 02-23-2012 |
Ester Freitsis, Ashdod IL
| Patent application number | Description | Published |
|---|---|---|
| 20100329568 | Networked Face Recognition System - A networked system for face recognition, the system comprising: a face verifier, configured to verify compliance of a face in an image with at least one predefined criterion, and upon successful verification of the compliance, to forward the image for feature extraction, a feature extractor, associated with the face verifier, configured to extract a feature from the forwarded image; and a face identifier, communicating with the feature extractor over a network, configured to receive the extracted feature and identify the face in the forwarded image, using the extracted feature. | 12-30-2010 |
| 20110091080 | Face Recognition System and Method - Apparatus for face recognition, the apparatus comprising: a face symmetry verifier, configured to verify symmetry of a face in at least one image, according to a predefined symmetry criterion, and a face identifier, associated with the face symmetry verifier, and configured to identify the face, provided the symmetry of the face is successfully verified. | 04-21-2011 |
Ester Fride, Ariel IL
| Patent application number | Description | Published |
|---|---|---|
| 20100099756 | USES OF INCENSOLE, INCENSOLE ACETATE AND DERIVATIVES THEREOF - The described subject matter relates to the use of incensole, incensole acetate, and derivatives thereof, for the treatment, prevention or amelioration of diseases or conditions, including inflammatory-associated conditions; a disease or condition where neuroprotection is required; and a disease or condition selected from depression, anxiety, obsessive compulsive behaviors, deterioration in cognitive function, and deterioration in neurobehavioral function. Pharmaceutical compositions and method of treatment, prevention or amelioration of the above-mentioned diseases or conditions are also provided. | 04-22-2010 |
Ester Fride, Efrat IL
| Patent application number | Description | Published |
|---|---|---|
| 20110172305 | Endocannabinoids for Enhancing Growth and Development in Infants - The present invention relates to a method for promoting infant feeding, growth or development comprising administering to an infant a formula or a pharmaceutical composition comprising an endocannabinoid in an amount sufficient to promote feeding, growth or development. The present invention also relates to an infant formula comprising an enhanced amount of an endocannabinoid. The infant formula of the invention may be in a powder form or in a liquid form. The infant formula or the pharmaceutical composition may further comprise an endocannabinoid-promoting compound. | 07-14-2011 |
Ester Martin Aparicio, Madrid ES
| Patent application number | Description | Published |
|---|---|---|
| 20090192204 | N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS - The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I) for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus. | 07-30-2009 |
| 20090221647 | N-(2-THIAZOLYL)-AMIDE DERIVATIVES AS GSK-3 INHIBITORS - The present invention relates to the use of N-(2-thiazolyl)-amide derivatives of formula (I), for the treatment and/or prophylaxis of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, especially neurodegenerative diseases, such as Alzheimer's disease, or non-insulin dependent diabetes mellitus. | 09-03-2009 |
Ester Masllorens, Girona ES
| Patent application number | Description | Published |
|---|---|---|
| 20100029944 | Process for the Synthesis of Solifenacin - This invention provides improved methods for making solifenacin and pharmaceutically acceptable salts thereof. The instant methods are unexpectedly advantageous in their simplicity and efficiency. | 02-04-2010 |
Ester Masllorens Llinas, Girona ES
| Patent application number | Description | Published |
|---|---|---|
| 20110015274 | FORM OF AN AMINOINDAN MESYLATE DERIVATIVE - The present disclosure relates generally to rasagiline mesylate with improved flowability and with advantageously reduced stickiness, to processes for the preparation thereof, and to the use thereof for milling and for preparing pharmaceutical formulations. Methods for improving the flowability and/or alleviating the stickiness of rasagiline mesylate having a very poor flowability and/or showing undesirable stickiness are also disclosed. | 01-20-2011 |
Ester Monlleó Mas, Barcelona ES
| Patent application number | Description | Published |
|---|---|---|
| 20120122868 | APAF-1 INHIBITOR COMPOUNDS - Derivatives of 2,5-piperazinedione of formula (I) are apoptotic peptidase activating factor 1 (Apaf-1) inhibitors, therefore they are useful as active pharmaceutical ingredients for the prophylaxis and/or treatment of a pathological and/or physiological condition associated with an increase of apoptosis. | 05-17-2012 |
Ester Parra Pastor, Parets Del Valles (barcelona) ES
| Patent application number | Description | Published |
|---|---|---|
| 20080226880 | Solvent Borne Polyurethane Composition - A solvent borne polyurethane composition with a polymodal molecular weight distribution comprising: i) 10 to 90 wt % of at least a polyurethane A with a Mw in the range of from 4,000 up to 25,000 g/mol, ii) 90 to 10 wt % of at least a polyurethane B with a Mw in the range of from 25,000 to 100,000 g/mol and iii) a liquid medium. | 09-18-2008 |
| 20080226881 | Solvent Borne Polyurethane Process - A process for obtaining a solvent borne polyurethane composition comprising preparing an isocyanate-terminated prepolymer A; reacting the isocyanate groups of isocyanate-terminated prepolymer A with 0.1 to 1.8 stoichiometric equivalents of at least one active-hydrogen containing chain terminating compound and or chain-extending compound; optionally introducing an isocyanate-terminated compound B; and reacting the isocyanate groups of the isocyanate-terminated prepolymer obtained in the previous steps and isocyanate-terminated compound B with 0 to 1.2 stoichiometric equivalents of at least one active-hydrogen containing chain-terminating compound and or chain-extending compound. | 09-18-2008 |
| 20100203301 | SOLVENT BORNE POLYURETHANE PROCESS - A process for obtaining a solvent borne polyurethane composition comprising preparing an isocyanate-terminated prepolymer A; | 08-12-2010 |
Ester Pri-Or US
| Patent application number | Description | Published |
|---|---|---|
| 20090080654 | Method to track the downloading and playing of audible presentations - A method for detecting playing of unauthorized downloading of digital data files having soundtracks by an Internet enabled machine including the steps of: (a) applying identification signals to the soundtracks at frequencies outside of human audible range; (b) encrypting the digital data files in a format requiring appropriate software to be played by media players; and (c) freely providing the appropriate software for playing the digital data files to generally available media players as an add on configured as a plug in downloadable form from an Internet website, where the appropriate software includes: | 03-26-2009 |
Ester Roi, San Juan Capistrano, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090253341 | HEATED DRAWING BOARD - A drawing board for use with a drawing media and a drawing sheet. The drawing media becomes softer upon being heated above an ambient temperature. The drawing board includes a board substrate having a drawing surface and an opposing backing surface. The drawing surface defines a first region and a second region. Each of the first and second regions is sized to substantially overlap with an entirety of the drawing sheet. The drawing board includes a heating element disposed adjacent the first region with the backing surface facing the heating element. The heating element and the first region is sized and configured to heat the first region above the ambient temperature. The drawing board includes a support housing supporting the drawing surface and the heating element. | 10-08-2009 |
Ester Rozenblum, Columbia, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090208939 | Identification of Molecular Diagnostic Markers for Endometriosis in Blood Lymphocytes - The invention comprises a method of identifying or predicting the predisposition to endometriosis in a female subject comprising determining the level of gene expression of at least one differentially-expressed gene or protein or peptide of peripheral blood leukocytes in a sample of peripheral blood leukocytes or peripheral blood in a subject to provide a first value, determining the level of gene expression of the at least one differentially-expressed gene or protein or peptide of said leukocytes in a control or reference standard to provide a second value, and comparing whether there is a difference between the first value and second value. | 08-20-2009 |
Ester Saison-Behmoaras, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20090312393 | CANCER THERAPY USING BCL-XL-SPECIFIC SINA - The invention relates to a double-stranded short interfering nucleic acid (siNA) molecule specific to the Bcl-X | 12-17-2009 |
Ester Yoles, Moshav Beit Gamliel IL
| Patent application number | Description | Published |
|---|---|---|
| 20110206706 | VACCINE AND METHOD FOR TREATMENT OF NEURODEGENERATIVE DISEASES - Methods and compositions are provided for treatment of neurodegenerative diseases in which there is accumulation of misfolded and/or aggregated proteins, excluding prion diseases. In particular, the invention relates to treatment of the neurodegenerative diseases Huntington's disease (HD), Alzheimer's disease (AD) or Parkinson's disease (PD), by administration of an agent selected from the group consisting of (i) Copolymer 1, (ii) a Copolymer 1-related peptide, (iii) a Copolymer 1-related polypeptide, and (iv) T cells activated with (i), (ii) or (iii). | 08-25-2011 |